According to a new market research report, published by Scalar Market Research, the global prescription pharmaceuticals market is expected to grow from $761.85 billion in 2016 and reach $918.74 billion by 2020, expanding at a compound annual growth rate (CAGR) of 4.8% during the forecast period.
Titled “Prescription Pharmaceuticals Market by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2020″, the report states the global prescription pharmaceuticals market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2020. It also focuses on the key drivers and opportunities in this market.
Key findings of the report:
Cardiovascular disorders expected to dominate the therapeutic segment of the market
According to the report, the cardiovascular disorders are expected to hold the largest share of the therapeutic segment of the prescription pharmaceuticals market, during the forecast period. The infectious diseases segment, on the other hand, is expected to become the fastest-growing segment. The major driving factors for these segments include the rise in aging population, changing lifestyles, and the growing demand from the emerging markets.
North America: Leading the prescription pharmaceuticals market
The report also finds that the North America region is expected to hold the largest market share during the forecast period. The major driving factors for the region include the rapid technological advancements, positive government initiatives, and the rising instances of chronic diseases. The Asia-Pacific region, on the other hand, is expected to be the fastest-growing geographic region in this market in the near future.
Apr 03, 2017 0